Garry Nolan's most recent trade in Akoya Biosciences Inc was a trade of 56,322 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akoya Biosciences Inc | Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 13 Dec 2022 | 100 | 555,084 | - | 13.3 | 1,325 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 02 Dec 2022 | 1,100 | 591,978 | - | 13.3 | 14,575 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.36 per share. | 01 Dec 2022 | 5,000 | 593,078 | - | 13.4 | 66,788 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 16 Nov 2022 | 300 | 598,078 | - | 13.3 | 3,976 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.29 per share. | 10 Nov 2022 | 20,000 | 598,978 | - | 13.3 | 265,858 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.31 per share. | 10 Nov 2022 | 3,810 | 618,978 | - | 13.3 | 50,705 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 10 Nov 2022 | 600 | 598,378 | - | 13.3 | 7,966 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 14 Sep 2022 | 8,305 | 622,788 | - | 13.3 | 110,084 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.31 per share. | 09 Sep 2022 | 22,191 | 632,893 | - | 13.3 | 295,338 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 09 Sep 2022 | 1,800 | 631,093 | - | 13.3 | 23,944 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 13 Dec 2021 | 100 | 555,084 | - | 13.3 | 1,325 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 09 Dec 2021 | 25,000 | 655,084 | - | 12.7 | 316,763 | Common Stock |
| Akoya Biosciences Inc | Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy |